BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 3182319)

  • 1. Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system.
    Curran WJ; Whittington R; Peters AJ; Fanning J
    Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):803-8. PubMed ID: 3182319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
    Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients.
    Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Huart J; Ganansia V; Milliez J; Blondon J; Housset M; Schlienger M
    Int J Radiat Oncol Biol Phys; 2001 May; 50(1):81-97. PubMed ID: 11316550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors.
    Chyle V; Zagars GK; Wheeler JA; Wharton JT; Delclos L
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):891-905. PubMed ID: 8751398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison.
    Perez CA; Grigsby PW; Camel HM; Galakatos AE; Mutch D; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):703-16. PubMed ID: 7860381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
    Fakiris AJ; Moore DH; Reddy SR; Look KY; Yiannoutsos CT; Randall ME; Cardenes HR;
    Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy.
    Sorbe B; Söderström K
    Anticancer Res; 2013 Jan; 33(1):241-7. PubMed ID: 23267151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of pelvic tumor control and impact on survival in carcinoma of the uterine cervix treated with radiation therapy alone.
    Perez CA; Kuske RR; Camel HM; Galakatos AE; Hederman MA; Kao MS; Walz BJ
    Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):613-21. PubMed ID: 3350717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study.
    Mahdi H; Rose PG; Elshaikh MA; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; DeBenardo R
    Gynecol Oncol; 2015 Mar; 136(3):529-33. PubMed ID: 25575483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.
    Morrow CP; Bundy BN; Kurman RJ; Creasman WT; Heller P; Homesley HD; Graham JE
    Gynecol Oncol; 1991 Jan; 40(1):55-65. PubMed ID: 1989916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bulky, barrel-shaped cervical carcinoma (stages IB, IIA, IIB): the prognostic factors for pelvic control and treatment outcome.
    Kim HK; Silver B; Berkowitz R; Howes A
    Am J Clin Oncol; 1999 Jun; 22(3):232-6. PubMed ID: 10362327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
    Mundt AJ; Murphy KT; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1154-60. PubMed ID: 11483324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated vaginal recurrences in endometrial carcinoma: treatment results using high-dose-rate intracavitary brachytherapy and external beam radiotherapy.
    Pai HH; Souhami L; Clark BG; Roman T
    Gynecol Oncol; 1997 Aug; 66(2):300-7. PubMed ID: 9264580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachytherapy for isolated vaginal recurrences from endometrial carcinoma.
    Colombo A; Cormio G; Placa F; Landoni F; Ardizzoia A; Gabriele A; Lissoni A
    Tumori; 1998; 84(6):649-51. PubMed ID: 10080669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
    Perez CA; Grigsby PW; Chao KS; Mutch DG; Lockett MA
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):307-17. PubMed ID: 9607346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation alone for carcinoma of the vagina: variation in response related to the location of the primary tumor.
    Ali MM; Huang DT; Goplerud DR; Howells R; Lu JD
    Cancer; 1996 May; 77(9):1934-9. PubMed ID: 8646695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting long-term outcome of irradiation in carcinoma of the vagina.
    Perez CA; Grigsby PW; Garipagaoglu M; Mutch DG; Lockett MA
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):37-45. PubMed ID: 10219792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.